Total planned funding: $181,155,682
Allocations
Countries/Regions
India | $181,155,682 |
Organizational Types
Unknown | $70,279,699 |
NGO | $54,049,599 |
Own Agency | $31,588,500 |
University | $16,032,112 |
Multi-lateral Agency | $2,850,000 |
Private Contractor | $2,589,272 |
FBO | $2,200,000 |
Host Country Government Agency | $939,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $61,913,739 |
Prevention | $49,492,732 |
Care | $27,441,943 |
Management and Operations | $22,615,199 |
Testing | $10,871,199 |
Treatment | $8,820,870 |
Budget Codes
OHSS: Health Systems Strengthening | $32,993,043 |
HVOP: Sexual Prevention: Other Sexual Prevention | $26,589,575 |
HVMS: Management and Operations | $22,615,199 |
HVSI: Strategic Information | $21,682,739 |
HBHC: Care: Adult Care and Support | $18,403,331 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,232,190 |
HVCT: Testing: HIV Testing and Counseling | $10,871,199 |
HTXS: Treatment: Adult Treatment | $8,237,469 |
HLAB: Laboratory Infrastructure | $7,237,957 |
HKID: Care: Orphans and Vulnerable Children | $4,918,163 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,445,080 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,872,025 |
HVTB: Care: TB/HIV | $3,506,413 |
HMBL: Biomedical Prevention: Blood Safety | $3,343,862 |
PDCS: Care: Pediatric Care and Support | $614,036 |
PDTX: Treatment: Pediatric Treatment | $559,924 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$69,655,210
Countries/Regions
USG Aggregated Agencies:
$18,446,018
Countries/Regions
FHI 360:
$17,564,011
Countries/Regions
Voluntary Health Services:
$10,660,000
Countries/Regions